Abstract:Warfarin, as well as other vitamin K antagonists, is the most widely used anticoagulant drug currently in clinical practice, and is mainly used to prevent thrombotic events due to heart valve replacement, atrial fibrillation and other diseases. However, there are many factors affecting its clinical efficacy, and the effective dose of warfarin varies greatly among individuals. With the in-depth study of warfarin pharmacogenomics, individualized warfarin medicine has gradually become possible. At present, the use of warfarin under genetic guidance is still controversial. This article reviewed the non-genetic factors and genetic factors that affect warfarin dose variation in order to provide a reference for disease precision treatment.